Results
|
|
3801.
|
|
|
|
3802.
|
|
|
|
3803.
|
Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial. [electronic resource] by
- Carlino, Matteo S
- Long, Georgina V
- Schadendorf, Dirk
- Robert, Caroline
- Ribas, Antoni
- Richtig, Erika
- Nyakas, Marta
- Caglevic, Christian
- Tarhini, Ahmed
- Blank, Christian
- Hoeller, Christoph
- Bar-Sela, Gil
- Barrow, Catherine
- Wolter, Pascal
- Zhou, Honghong
- Emancipator, Kenneth
- Jensen, Erin H
- Ebbinghaus, Scot
- Ibrahim, Nageatte
- Daud, Adil
Producer: 20190415
In:
European journal of cancer (Oxford, England : 1990) vol. 101
Availability: No items available.
|
|
|
3804.
|
Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. [electronic resource] by
- Lin, Chao
- He, Hongyong
- Liu, Hao
- Li, Ruochen
- Chen, Yifan
- Qi, Yangyang
- Jiang, Qi
- Chen, Lingli
- Zhang, Peipei
- Zhang, Heng
- Li, He
- Zhang, Weijuan
- Sun, Yihong
- Xu, Jiejie
Producer: 20191017
In:
Gut vol. 68
Availability: No items available.
|
|
|
3805.
|
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma. [electronic resource] by
- Sobhani, N
- Roviello, G
- Pivetta, T
- Ianza, A
- Bonazza, D
- Zanconati, F
- Giudici, F
- Bottin, C
- Corona, S P
- Guglielmi, A
- Rizzardi, C
- Milione, M
- Cortale, M
- Confalonieri, M
- Generali, D
Producer: 20200106
In:
Molecular biology reports vol. 46
Availability: No items available.
|
|
|
3806.
|
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma. [electronic resource] by
- Turkington, Richard C
- Knight, Laura A
- Blayney, Jaine K
- Secrier, Maria
- Douglas, Rosalie
- Parkes, Eileen E
- Sutton, Eilis K
- Stevenson, Leanne
- McManus, Damian
- Halliday, Sophia
- McCavigan, Andrena M
- Logan, Gemma E
- Walker, Steven M
- Steele, Christopher J
- Perner, Juliane
- Bornschein, Jan
- MacRae, Shona
- Miremadi, Ahmad
- McCarron, Eamon
- McQuaid, Stephen
- Arthur, Kenneth
- James, Jacqueline A
- Eatock, Martin M
- O'Neill, Robert
- Noble, Fergus
- Underwood, Timothy J
- Harkin, D Paul
- Salto-Tellez, Manuel
- Fitzgerald, Rebecca C
- Kennedy, Richard D
Producer: 20191031
In:
Gut vol. 68
Availability: No items available.
|
|
|
3807.
|
PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer. [electronic resource] by
- Kawahara, Takashi
- Ishiguro, Yukari
- Ohtake, Shinji
- Kato, Ikuma
- Ito, Yusuke
- Ito, Hiroki
- Makiyama, Kazuhide
- Kondo, Keiichi
- Miyoshi, Yasuhide
- Yumura, Yasushi
- Hayashi, Narihiko
- Hasumi, Hisashi
- Osaka, Kimito
- Muraoka, Kentaro
- Izumi, Koji
- Teranishi, Jun-Ichi
- Uemura, Hiroji
- Yao, Masahiro
- Nakaigawa, Noboru
Producer: 20190225
In:
BMC urology vol. 18
Availability: No items available.
|
|
|
3808.
|
|
|
|
3809.
|
|
|
|
3810.
|
|
|
|
3811.
|
A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses. [electronic resource] by
- Zimmer, Alexandra S
- Nichols, Erin
- Cimino-Mathews, Ashley
- Peer, Cody
- Cao, Liang
- Lee, Min-Jung
- Kohn, Elise C
- Annunziata, Christina M
- Lipkowitz, Stanley
- Trepel, Jane B
- Sharma, Rajni
- Mikkilineni, Lekha
- Gatti-Mays, Margaret
- Figg, William D
- Houston, Nicole D
- Lee, Jung-Min
Producer: 20200624
In:
Journal for immunotherapy of cancer vol. 7
Availability: No items available.
|
|
|
3812.
|
|
|
|
3813.
|
|
|
|
3814.
|
|
|
|
3815.
|
|
|
|
3816.
|
Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab. [electronic resource] by
- Morita, Mitsunori
- Tamiya, Motohiro
- Fujimoto, Daichi
- Tamiya, Akihiro
- Suzuki, Hidekazu
- Hirano, Katsuya
- Fukuda, Yasushi
- Yokoyama, Toshihide
- Kominami, Ryota
- Kanazu, Masaki
- Uchida, Junji
- Hara, Satoshi
- Yamashita, Shuji
- Tomioka, Hiromi
Producer: 20200930
In:
BMC cancer vol. 20
Availability: No items available.
|
|
|
3817.
|
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries. [electronic resource] by
- Cembrola, Biancamaria
- Ruzza, Valentino
- Troise, Fulvia
- Esposito, Maria Luisa
- Sasso, Emanuele
- Cafaro, Valeria
- Passariello, Margherita
- Visconte, Feliciano
- Raia, Maddalena
- Del Vecchio, Luigi
- D'Alise, Anna Morena
- Cortese, Riccardo
- Scarselli, Elisa
- Zambrano, Nicola
- De Lorenzo, Claudia
- Nicosia, Alfredo
Producer: 20200706
In:
BioMed research international vol. 2019
Availability: No items available.
|
|
|
3818.
|
|
|
|
3819.
|
Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis. [electronic resource] by
- Yan, Xiaoming
- Gu, Yanzheng
- Wang, Caiqin
- Sun, Simao
- Wang, Xiaozhu
- Tian, Jingluan
- Wang, Mingyuan
- Ji, Xiaopei
- Duan, Xiaoyu
- Gao, Hanqing
- Fang, Qi
- Dong, Wanli
- Zhang, Xueguang
- Xue, Qun
Producer: 20200518
In:
Clinical immunology (Orlando, Fla.) vol. 207
Availability: No items available.
|
|
|
3820.
|
Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses. [electronic resource] by
- de Mare-Bredemeijer, Emmy L D
- Mancham, Shanta
- Verstegen, Monique M A
- de Ruiter, Petra E
- van Gent, Rogier
- O'Neill, David
- Tilanus, Hugo W
- Metselaar, Herold J
- de Jonge, Jeroen
- Kwekkeboom, Jaap
- Hall, Sean R R
- van der Laan, Luc J W
Producer: 20160222
In:
Stem cells and development vol. 24
Availability: No items available.
|